Lower serum threonine and glutamine levels could be a predictor for multiple sclerosis in pregnancy
- 17 February 2026
- journal article
- Published by Taylor & Francis in Scandinavian Journal of Clinical and Laboratory Investigation
- Vol. 86 (2) , 181-191
Abstract
No abstract availableThis publication has 40 references indexed in Scilit:
- Longitudinal Metabolite Changes in Progressive Multiple Sclerosis: A Study of 3 Potential Neuroprotective TreatmentsJournal of Magnetic Resonance Imaging, 2023
- Escalation Versus Induction/High-Efficacy Treatment Strategies for Relapsing Multiple Sclerosis: Which is Best for Patients?Drugs, 2023
- A metabolome-wide Mendelian randomization study prioritizes potential causal circulating metabolites for multiple sclerosisJournal of Neuroimmunology, 2023
- Metabolomic profiles in relapsing–remitting and progressive multiple sclerosis compared to healthy controls: a five-year follow-up studyMetabolomics, 2023
- Inflammation and kynurenine pathway dysregulation in post-partum women with severe and suicidal depressionBrain, Behavior, and Immunity, 2020
- The clinical course of multiple sclerosis2014
- Recall rate and positive predictive value of MSUD screening is not influenced by hydroxyprolineEuropean Journal of Pediatrics, 2008
- Pregnancy and multiple sclerosis: The children of PRIMSClinical Neurology and Neurosurgery, 2006
- Metabolite Changes in Normal-Appearing Gray and White Matter Are Linked With Disability in Early Primary Progressive Multiple SclerosisArchives of Neurology, 2005
- Preliminary studies of cytokine secretion patterns associated with pregnancy in MS patientsJournal of the Neurological Sciences, 2004